NIH Plans To Create "Phenotype Atlas" Of Orphan Diseases
Coinciding with the 25th anniversary of the Orphan Drug Act and the establishment of the National Organization for Rare Disorders, the National Institutes of Health announced May 19 an "Undiagnosed Diseased Program" to focus on the most puzzling medical cases referred to the NIH Clinical Center.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth